Pantec Reports Success In Transdermal Patch Trials

Some patients fear injections so much that they avoid getting proper medical treatment, sometimes with life-threatening results. Transdermal patches, which administer drugs through the skin, could make the bite of the needle a mere unpleasant memory. One company having success in this area is Pantec...

GlaxoSmithKline, Pfizer Team Up Against HIV

The collaboration of two pharmaceutical giants may mark the beginning of an industry shift. GlaxoSmithKline and Pfizer are combining their HIV drug businesses into a single, jointly owned company that will account for almost 20 percent of the market.  The new company will have a portfolio of 11 existing...

NIH Proposal Expands Stem Cell Funding

Embryonic stem-cell research would get a financial boost under a new proposal by the National Institutes of Health. According to the Wall Street Journal, the NIH guidelines expand funding for cell lines derived from surplus human embryos (those left over from fertility treatments). During the Bush era,...

[Company Profile] Reata Pharmaceuticals

According to the National Kidney Foundation, over 26 million Americans suffer from chronic kidney disease (CKD), a progressive condition in which the kidneys allow waste to build up in the blood. CKD can eventually lead to kidney failure, requiring dialysis or a transplant. It is also associated with a...

Cellular Reprogramming May Offer Stem-Cell Compromise

President Obama’s recent reversal of Bush’s policy on embryonic stem cell research reignited the debate over the ethical limits of science. Proponents of embryonic stem cell research argue that the cells have the potential to cure disease, while opponents object to the destruction of human embryos....

Radiology Start-Up Raises $10 Million

Foundation Radiology Group, a provider of diagnostic imaging services to hospitals and medical institutions, announced that it has raised $10 million in the company’s first round of venture funding. The round was led by Chrysalis Ventures with participation from Health Evolution Partners. Pittsburgh-based...

Pentagon Developing Bionic Arm

While prosthetic legs have undergone remarkable advances in the past decades, the typical prosthetic arm hasn’t changed much since World War II: an artificial limb with a hook on the end. It’s a less than thrilling prospect for U.S. soldiers returning from Iraq or Afghanistan with amputated...

Burrill to Invest $1 Billion In Biotech Project

The economic climate may be grim, but biotech banker G. Steven Burrill is looking to the future. The CEO of Burrill and Co. plans to invest $1 billion into Minnesota’s Pine Island biotechnology project and a private equity/venture capital fund. The fund will support the development of new technologies from...